Biodesix, Inc. (BDSX)
NASDAQ: BDSX · Real-Time Price · USD
18.72
-0.68 (-3.51%)
At close: Mar 10, 2026, 4:00 PM EDT
19.69
+0.97 (5.18%)
After-hours: Mar 10, 2026, 7:12 PM EDT
Biodesix Market Cap
Biodesix has a market cap or net worth of $184.55 million as of March 10, 2026. Its market cap has increased by 43.84% in one year.
Market Cap
184.55M
Enterprise Value
240.59M
1-Year Change
43.84%
Ranking
Category
Stock Price
$18.72
Market Cap Chart
Since October 28, 2020, Biodesix's market cap has decreased from $336.31M to $184.55M, a decrease of -45.13%. That is a compound annual growth rate of -10.58%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 9, 2026 | 191.25M | 253.52% |
| Dec 31, 2025 | 54.10M | -75.69% |
| Dec 31, 2024 | 222.56M | 33.69% |
| Dec 29, 2023 | 166.48M | -5.38% |
| Dec 30, 2022 | 175.94M | 23.06% |
| Dec 31, 2021 | 142.97M | -73.28% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Oct 28, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Personalis | 853.80M |
| Castle Biosciences | 803.34M |
| Fulgent Genetics | 464.71M |
| Myriad Genetics | 449.77M |
| Prenetics Global | 344.81M |
| Burning Rock Biotech | 242.03M |
| Insight Molecular Diagnostics | 173.70M |
| MDxHealth | 173.61M |